Investors & Media

Welcome to the Investor Relations and Public Relations division of Medigene AG. This is where you will find current information on a variety of subjects, including Medigene AG shares, company news, financial reports and key figures.

Latest News

Medigene announces participation at six upcoming investor and scientific conferences

SHOW RELEASE

Expitope 2.0 helps to identify safer antigens for immunotherapy of cancer

SHOW RELEASE

Medigene collaborates with RXi Pharmaceuticals to further sharpen its therapeutic T cells

SHOW RELEASE

The Medigene Share

The Medigene share MDG1 (ISIN:DE000A1X3W00 ) is listed at the Frankfurt Stock Exchange since June 2000. The share is part of TecDAX, an index of the Deutsche Börse (German Stock Exchange) that includes Germany's most important mid-cap technology companies.

show medigene share

Events

22 - 24 Jan 2018

Precision Medicine World Conference (PMWC) 2018

Mountain View, CA, USA

25 - 27 Jan 2018

ASCO-SITC Clinical Immuno-Oncology Symposium

San Francisco, USA

22 Mar 2018

Annual Report 2017

09 May 2018

3-Months Report 2018

07 Aug 2018

6-Months Report 2018

13 Nov 2018

9-Months Report 2018

Reports & Presentations

2017

Medigene corporate presentation December 2017

DownLoad (2 MB)

2017

Presentation on occasion of the 9 Months Report 2017

DownLoad (661 KB)

2017

9 Months Report 2017

DownLoad (2 MB)

Annual General Meeting 2017

The Annual General Meeting of Medigene shareholders for fiscal year 2016 was held on Wednesday, 24 May 2017 at the Conference Center Munich of the Hanns-Seidel-Stiftung in Munich (Lazarettstr. 33, 80636 Munich). 

read more

Corporate Governance

Good corporate governance is the basis of our decision-making and monitoring processes. It stands for responsible and value-based leadership and control of the Company for long-term success, goal-oriented and efficient cooperation between the Executive Board and Supervisory Board, respect for the interests of our shareholders and employees, consistently transparent and responsible corporate decisions and an appropriate risk management system.

read more

press photos

Laboratory work (1)

HPLC loading with samples

DownLoad (2 MB)

Laboratory work (2)

Weighing of a substance

DownLoad (8 MB)

Laboratory work (3)

Sampling from a nitrogen tank

DownLoad (9 MB)

Contact person

Julia Hofmann
Senior Director, Head of Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20

Dr. Robert Mayer
Senior Manager Public & Investor Relations
investor(at)medigene.com
public.relations(at)medigene.com
Telefon: +49-89-20 00 33-33 01
Fax: +49-89-20 00 33-29 20